Active, not recruitingPhase 4NCT04586660
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
Studying Giant cell tumor of bone
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Amgen
- Principal Investigator
- MDAmgen
- Intervention
- XGEVA®(drug)
- Enrollment
- 36 target
- Eligibility
- 12 years · All sexes
- Timeline
- 2023 – 2028
Study locations (10)
- Beijing Jishuitan Hospital, Beijing, Beijing Municipality, China
- Peking University Peoples Hospital, Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
- The Third Affiliated Hospital Of Southern Medical University, Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
- Harbin Meidical University Cancer Hospital, Harbin, Heilongjiang, China
- Tangdu Hospital of Air Force Medical University, Xi'an, Shaanxi, China
- The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
- National Taiwan University Hospital, Taipei, Taiwan
- Taipei Veterans General Hospital, Taipei, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04586660 on ClinicalTrials.govOther trials for Giant cell tumor of bone
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07315828Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone SurgeryShanghai Jiao Tong University Affiliated Sixth People's Hospital
- RECRUITINGNCT07227961PROMIS and Mobility Evaluation in Sarcoma PatientsUniversity of Calgary
- RECRUITINGPHASE1, PHASE2NCT06647901Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open StudyTang Xiaodong
- RECRUITINGPHASE2NCT05595603Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional CurettageSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE3NCT03295981Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of BoneSt. Louis University